D-1190-2014 Class III Terminated

Recalled by Teva Pharmaceuticals USA — Horsham, PA

FDA drug recall D-1190-2014 was initiated by Teva Pharmaceuticals USA on Feb 11, 2014 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point The recall status is terminated (terminated Nov 14, 2014). Affected quantity: 257,832 cylinders.

Recall details

Product Type
Drugs
Report Date
Apr 9, 2014
Initiation Date
Feb 11, 2014
Termination Date
Nov 14, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
257,832 cylinders

Product description

QVAR¿ (beclomethasone dipropionate HFA), C4 INHALATION AEROSOL in Aluminum Cylinders, Mktd by: Teva Respiratory, LLC, Horsham, PA 19044 Mfd by: 3M Drug Delivery Systems, Northridge, CA 91324.

Reason for recall

Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point

Distribution pattern

Nationwide

Code information

lot 120088, exp.3/2014, NDC 59310-202-40, 40 mcg,8.7g / 120 metered inhalations, lot 120491, exp. 10/2014, NDC 59310-175-41,40 mcg,7.3g / 100 metered inhalations

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1190-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1190-2014. Report a data issue: hello@regdatalab.com.